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Abstract
Angiotensin II (AG II) stimulates the ouabain-insensitive, furosemide- sensitive Na-ATPase present in the basolateral
membrane of pig renal proximal tubules in a dose dependent manner. Maximum effect was obtained with 1038 M AG II,
which corresponded to an activity 134% higher than control. Half of the maximum effect was observed between 10311 M and
10310 M, corresponding to physiological hormone levels. Saralasin, an AG II peptide analogue receptor antagonist,
abolished the phenomenon, demonstrating that AG II interacts with specific sites in pig proximal tubules. The AG II
stimulatory effect was also prevented by dithiothreitol (DTT), a reducing compound, and by 10 nM losartan, a non-peptide
antagonist highly specific for AT1 receptors, characterizing AG II binding to AT1 receptors. GTPQS, a non-hydrolysable
GTP analogue, increased by 159% the enzyme activity as compared to the control values. The simultaneous addition of
1035 M GTPQS and 1038 M AG II did not have additive effects. Furthermore, the stimulatory action of AG II was
completely abolished by 0.1 WM GDPLS, a non-hydrolysable GDP analogue. Two Wg ml31 pertussis toxin, an inhibitor of
Gi-protein, did not modulate the AG II stimulatory effect. On the other hand, the Na-ATPase activity was enhanced 100%
in the presence of cholera toxin and 85% in the presence of both AG II and cholera toxin. Taken together, these data suggest
that AG II activates the Na-ATPase activity through AT1 receptors coupled to a pertussis-insensitive and cholera-sensitive
G-protein. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The renin^angiotensin system plays a crucial role
in the regulation of extracellular volume through in-
direct and direct e¡ects on renal sodium excretion
[1]. It has been described that angiotensin II (AG
II) directly modulates Na reabsorption in di¡erent
segments of the nephron, including the proximal tu-
bule [2^7]. Micropuncture and microperfusion stud-
ies performed in rat and rabbit renal proximal tu-
bules demonstrated that AG II modulates sodium
reabsorption in a dose dependent and biphasic man-
ner [2,3]. Physiological doses of AG II, between
10312 M and 10310 M, stimulate sodium reabsorp-
tion, whereas higher AG II concentrations, between
1037 M and 1035 M, are inhibitory. However, the
mechanism involved is not well understood.
AG II e¡ects are due to its binding to speci¢c
receptors on the plasma membrane of the target tis-
sues, which were characterized and cloned [8,9]. In
renal tissue, they have been classi¢ed as AT1, AT2,
and non-AT1/non-AT2 (also designated as AG III/
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AG IV) according to their pharmacological and mo-
lecular characteristics [8,9]. The AT1 receptors are
the most abundant type found in the adult kidney,
and were described as a protein of about 65 kDa
with seven transmembrane domains and four cys-
teine residues, being coupled to a G-protein and sus-
ceptible to the reducing power of thiols [8]. The AT2
receptors, on the other hand, are detected mainly in
foetal tissues representing only 10% of AG II recep-
tors in the adult kidney and are activated by thiols
[10]. It is relevant that AG II receptors are present
on the brush-border and basolateral membranes of
the proximal tubule [11,12].
The activity of the ATPases and the process of
Na reabsorption are correlated. There is a promi-
nent expression of Na,K-ATPase in the renal
proximal tubule cells, which provides the energy gra-
dient that supplies the transcellular sodium reabsorp-
tion in this segment of the nephron. In the past dec-
ade, a second Na-ATPase, which is insensitive to
ouabain and sensitive to furosemide, was described
in several animal tissues [13^16]. This Na-ATPase
transports Na against an electrochemical gradient
and is not stimulated by K. In proximal tubule cells
this enzyme is localized in the basolateral membrane
and is involved with the extrusion of sodium along
with chloride and water [13]. In spite of several pa-
pers published on this enzyme, its physiological role
remains to be elucidated. It was ¢rst suggested that
the Na-ATPase could be involved in cell volume
regulation [13,15]. Recently, our laboratory proposed
that this enzyme involved in the regulation of Na
reabsorption in the proximal tubule is the primary
active transport target for natriuretic compounds
[17,18]. Munday and colleagues [19] showed previ-
ously that 10312 M AG II stimulates sodium and
£uid reabsorption via the ouabain-insensitive Na-
ATPase in rat kidney slices.
Based on the hypothesis that AG II regulates
proximal sodium transport, the purpose of this study
was to investigate the modulation of Na-ATPase
and Na,K-ATPase activities by AG II, as well
as the possible signal transduction pathway in-
volved.
Our results show that AG II stimulates the Na-
ATPase activity through the AT1 receptor but does
not change the Na,K-ATPase activity.
2. Materials and methods
2.1. Materials
ATP, ouabain, furosemide, azide, EGTA, manni-
tol, angiotensin II, pertussis toxin, cholera toxin,
saralasin (Sar1Ile8-AG II) and GTPQS were pur-
chased from Sigma Chemical Co., St. Louis, MO,
USA. Percoll was purchased from Pharmacia Bio-
tech, Uppsala, Sweden. All chemicals reagents were
of the highest purity available. [32P]Pi was obtained
from the Institute of Energetic and Nuclear
Research, Sa‹o Paulo, SP, Brazil.
All solutions were prepared with deionized glass-
distilled water. [Q-32P]ATP was prepared as described
by Maia and coworkers [20].
2.2. Preparation of cortex homogenates and isolated
basolateral membrane
Cortex homogenates and basolateral membranes
were prepared from adult pig kidney. The kidneys
were obtained from a commercial slaughter house
immediately after the death of the animals, and
maintained at 4‡C in a solution containing (mM):
250 sucrose, 10 Hepes^Tris (pH 7.6), 2 EDTA and
1 phenylmethanesulfonyl £uoride (PMSF) [17,18].
Thin slices were removed from the cortex (cortex-
corticis) with a scalpel. After dissection, slices were
homogenized in the same cold solution with a Te£on
and glass homogenizer. The homogenate was centri-
fuged for 10 min at 3000 rpm in a Sorvall centrifuge
using a SS-34 rotor at 4‡C. The supernatant was
collected and stored at 34‡C. The fraction contain-
ing the basolateral membrane was isolated by the
Percoll gradient method [21]. The membrane prepa-
ration was resuspended in 250 mM sucrose to a ¢nal
concentration between 20^30 mg of protein ml31 and
was stored at 34‡C.
2.3. Measurement of ATPase activity
Except as noted under Section 3, the composition
of the standard assay medium (0.2 ml) contained:
10 mM MgCl2 ; 5 mM [Q-32P]ATP; 20 mM Hepes^
Tris (pH 7.0); 5 mM azide; 1 mM EGTA; and
90 mM NaCl, for measuring of the Na-ATPase
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activity. The ¢nal osmolality was adjusted with man-
nitol to 300 mosmol kg31.
The ATPase activity was measured according to
the method described by Grubmeyer and Penefsky
[22]. The reaction was started by the addition of
cortex homogenate or isolated basolateral membrane
to a ¢nal protein concentration of 0.3^0.5 mg ml31.
The reaction was stopped after 30 min by the addi-
tion of charcoal activated by HCl (0.1 N). The [32P]Pi
released was measured in an aliquot of the superna-
tant obtained after centrifugation of the charcoal
suspension for 20 min at 3000 rpm in a clinical cen-
trifuge. Spontaneous hydrolysis of [Q-32P]ATP was
measured simultaneously in tubes where protein
was added after the acid. The Na-ATPase activity
was calculated by the di¡erence between the [32P]Pi
released in the absence and in the presence of 2 mM
furosemide, both in the presence of 1 mM ouabain
[23,24]. The Na,K-ATPase activity was calculated
by the di¡erence between the [32P]Pi released in the
absence and in the presence of 1 mM ouabain [25].
The Na,K-ATPase activity measured in isolated
basolateral membrane is ¢ve times higher when com-
pared to the activity found in cortex homogenate.
Protein concentrations were determined by the Folin
phenol method [26] using bovine serum albumin as a
standard. Each experiment was performed in an in-
dependent preparation of basolateral membrane or
cortex homogenate. The data were analysed by
two-way analysis of variance (ANOVA), considering
the treatments as factors. The signi¢cance of the dif-
ferences was veri¢ed by the Bonferroni t-test. Statis-
tical analysis was performed using absolute values
and the results were expressed as percentage of the
control.
3. Results
3.1. E¡ect of AG II on the Na+-ATPase and
Na+,K+-ATPase activities
To verify the AG II modulation on the second
sodium pump, its activity was measured in the ab-
sence and in the presence of di¡erent concentrations
of the hormone (10311 M to 1036 M) in isolated
basolateral membrane and cortex homogenate prep-
arations (Fig. 1). In both preparations AG II en-
hanced the Na-ATPase activity in a dose dependent
manner. The enzyme activity increased from
4.28 þ 0.21 to 10.00 þ 1.38 nmol 32Pi min31 mg31 in
basolateral membrane, and from 1.10 þ 0.26 to
Fig. 1. Dependence of Na-ATPase (F) and Na,K-ATPase
(b) activities in cortex homogenate (F,b) and isolated basolater-
al membrane (E,a) of renal proximal tubule on AG II concen-
tration. ATPase activity was measured as described in Section 2
(n = 7). The AG II concentration was increased from 10311 M
to 1036 M. Results are expressed as percentage of the control
(R). *Statistically signi¢cant when compared to control
(P6 0.05).
Fig. 2. Inhibition of the e¡ect of AG II on Na-ATPase activ-
ity in isolated basolateral membrane of renal proximal tubule
by 1039 M saralasin (Sar). ATPase activity was measured as
described in Section 2 (n = 6). 1038 M AG II was added where
indicated. Results are expressed as absolute values of the en-
zyme activity. *Statistically signi¢cant when compared to con-
trol (P6 0.05).
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2.63 þ 0.76 nmol 32Pi min31 mg31 in cortex homoge-
nate, corresponding to an increase of 134% and
139%, respectively. The maximum stimulatory action
was observed at 1038 M AG II. Since the e¡ects
in isolated basolateral membrane and in cortex ho-
mogenate were similar, it is reasonable to conclude
that all signal transduction pathway elements acti-
vated by AG II during the stimulation of Na-AT-
Pase were preserved in the isolated basolateral mem-
brane.
The Na,K-ATPase activity in isolated basolat-
eral membrane and cortex homogenate was not
changed by increasing AG II concentrations, from
10311 to 1036, as shown in Fig. 1.
3.2. Characterization of the receptor involved in the
stimulation of the Na+-ATPase activity by AG II
Brown and Douglas [10,11] had previously docu-
mented that AG II receptors are present in both
luminal and basolateral membrane of the proximal
tubules. To characterize AG II interaction with baso-
lateral membrane receptors from pig renal proximal
tubules, we used saralasin, an AG II analogue pep-
tide receptor antagonist [27]. Data illustrated in Fig.
2 show that the AG II stimulatory e¡ect on the Na-
ATPase activity in isolated basolateral membrane
was completely abolished by 1039 M saralasin. Fur-
thermore, 1039 M saralasin alone did not change the
enzyme activity. These data indicate that AG II stim-
Fig. 3. Modulation of the e¡ect of AG II on Na-ATPase ac-
tivity in isolated basolateral membrane of renal proximal tubule
by 1 mM dithiothreitol (DTT). ATPase activity was measured
as described in Section 2 (n = 5). 1038 M AG II was added
where indicated. Results are expressed as absolute values of the
enzyme activity. *Statistically signi¢cant when compared to
control (P6 0.05).
Fig. 4. Reversal of the e¡ect of AG II on Na-ATPase activity
in isolated basolateral membrane of renal proximal tubule by
losartan (Los). Losartan concentration was increased from
10310 M to 1037 M. 1038 M AG II was added where indicated.
ATPase activity was measured as described in Section 2 (n = 6).
Results are expressed as absolute values of the enzyme activity.
*Statistically signi¢cant when compared to control (P6 0.05).
Fig. 5. Modulation of the e¡ect of AG II on Na-ATPase ac-
tivity in isolated basolateral membrane of renal proximal tubule
by PD 123319. The concentration of PD 123319 was increased
from 40 nM to 2 WM. Where indicated 1038 M AG II was
added. ATPase activity was measured as described in Section 2
(n = 5). Results are expressed as absolute values of the enzyme
activity. *Statistically signi¢cant when compared to control
(P6 0.05).
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ulates the Na-ATPase activity through its interac-
tion with speci¢c plasma membrane receptors.
Additional information concerning the type of re-
ceptor mediating the activation of Na-ATPase by
AG II was obtained with the use of the thiol dithio-
threitol (DTT). Initially, the isolated basolateral
membrane fraction was incubated with 1 mM DTT
for 10 min. After the pre-incubation, Na-ATPase
activity was measured in the presence of 1 mM
DTT. In this condition, Na-ATPase activity was
3.96 þ 0.40 nmol 32Pi min31 mg31 in the absence of
the hormone, and 4.78 þ 1.19 nmol 32Pi min31 mg31
in the presence of 1038 M AG II (Fig. 3). To rule out
the possibility that the lack of AG II stimulatory
e¡ect on the Na-ATPase could be due to pre-incu-
bation with DTT, a simultaneous experiment was
run in which the enzyme was pre-incubated in the
absence of DTT and its activity was also measured.
Under this situation, the enzyme activity increased
from 4.50 þ 0.90 nmol 32Pi min31 mg31, in the ab-
sence of AG II, to 8.97 þ 0.20 nmol 32Pi min31 mg31,
in the presence of 1038 M AG II.
One of the di¡erences among the AG II receptors
is the sensitivity to losartan, a non-peptide antago-
nist. Our data illustrated in Fig. 4 show that the
stimulatory e¡ect of AG II was abolished by losartan
in a dose-dependent manner. Complete reversal of
the e¡ect of AG II was obtained in the presence of
1038 M losartan. The ATPase activity decreased
from 7.38 þ 0.64 nmol 32Pi min31 mg31, in the pres-
ence of AG II, to 4.48 þ 0.77 nmol 32Pi min31 mg31,
in the presence of AG II plus losartan, a level similar
to that obtained in the absence of both drugs. The
addition of 1038 M losartan alone did not change the
Na-ATPase activity. Furthermore, PD 123319, a
speci¢c antagonist of AT2 receptor [28], did not
change the stimulatory e¡ect of AG II on the Na-
ATPase activity (Fig. 5).
Taken together, these data indicate that the AG II
stimulatory e¡ect on the Na-ATPase is mediated by
its interaction with AT1 receptors present in the
basolateral membrane of renal proximal tubule.
3.3. Coupling of AG II receptors to G-protein during
activation of Na+-ATPase activity
Signal transduction pathways activated by AG II
are, in general, coupled to G-proteins [27]. To verify
the involvement of a G-protein in the activation of
the Na-ATPase by AG II, a non-hydrolysable GTP
Fig. 6. Modulation of the e¡ect of AG II on Na-ATPase ac-
tivity in isolated basolateral membrane of renal proximal tubule
by GTPQS. GTPQS concentration was increased from 1039 M
to 1035 M. 1038 M AG II was added where indicated. ATPase
activity was measured as described in Section 2 (n = 4). Results
are expressed as absolute values of the enzyme activity. *Statis-
tically signi¢cant when compared to control (P6 0.05).
Fig. 7. Modulation of the e¡ect of AG II on Na-ATPase ac-
tivity in isolated basolateral membrane of renal proximal tubule
by GDPLS. GDPLS concentration was increased from 0.1 WM
to 100 WM. Where indicated, 1038 M AG II was added. AT-
Pase activity was measured as described in Section 2 (n = 4).
Results are expressed as absolute values of the enzyme activity.
*Statistically signi¢cant when compared to control (P6 0.05).
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analogue, GTPQS, and a non-hydrolysable GDP ana-
logue, GDPLS, was used. The results presented in
Fig. 6 show that the increase in GTPQS concentration
(from 1039 M to 1035) raised, in a dose-dependent
manner, the Na-ATPase activity from 4.80 þ 0.43 to
12.47 þ 1.36 nmol 32Pi min31 mg31, corresponding to
an activity 159% higher than the control. Similar
results were obtained with AG II alone, as men-
tioned before. Maximal e¡ect was obtained in the
presence of 1036 M GTPQS. In addition, the concom-
itant use of 1038 M AG II and 1035 M GTPQS in-
creased the enzyme activity 2.4 times above control
levels (11.46 þ 0.97 nmol 32Pi min31 mg31). Since AG
II and GTPQS stimulatory e¡ects were not additive it
might be possible that they act in the same trans-
duction pathway to modulate the Na-ATPase activ-
ity. In addition, data illustrated in Fig. 7 demon-
strate the reversal of AG II stimulatory e¡ect on
the enzyme activity by a non-hydrolysable GDP ana-
logue, GDPLS. The Na-ATPase activity in the pres-
ence of 1038 M AG II raised from 4.70 þ 0.18 nmol
32Pi min31 mg31 (control) to 7.99 þ 0.70 nmol 32Pi
min31 mg31. Besides, the simultaneous addition of
1038 M AG II and di¡erent concentrations of
GDPLS (from 0.1 WM to 100.0 WM), abolished the
hormone action. In this situation, the enzyme activity
was 4.29 þ 0.16 nmol 32Pi min31 mg31, in the pres-
ence of both 1038 M AG II and 100 WM GDPLS
(values statistically similar to the control). It is rele-
vant that 200 WM GDPLS has no e¡ect on the Na-
ATPase activity.
It has been proposed that the e¡ect of AG II on
£uid reabsorption in the proximal tubule is mediated
by cyclic adenosine 3P,5P-monophosphate (cAMP)
[28]. The level of cAMP depends on modulation of
the adenylyl cyclase by stimulatory G-proteins (Gs)
and inhibitory G-proteins (Gi). One of the principal
characteristics of Gi-protein is its sensitivity to per-
tussis toxin, whereas the Gs protein is sensitive to
cholera toxin [29]. To verify the possible involvement
of the Gi-protein in the stimulatory e¡ect of AG II
on the Na-ATPase activity, pertussis toxin was
used. Fig. 8 describes the data obtained with experi-
ments designed to verify the modulation of 1038 M
AG II e¡ect on the Na-ATPase activity by di¡erent
concentrations of pertussis toxin. Increase in pertus-
sis concentration from 0.1 Wg ml31 to 2.0 Wg ml31
did not change the 1038 M AG II stimulatory e¡ect
on the Na-ATPase activity. Furthermore, 1 Wg ml31
Fig. 9. Modulation of the e¡ect of AG II on Na-ATPase ac-
tivity in isolated basolateral membrane of renal proximal tubule
by 1039 M cholera toxin (Chol. Tx.). ATPase activity was
measured as indicated in Section 2 (n = 5). 1038 M AG II was
added where indicated. Results are expressed as absolute values
of the enzyme activity. *Statistically signi¢cant when compared
to control (P6 0.05).
Fig. 8. Modulation of the e¡ect of AG II on Na-ATPase ac-
tivity in isolated basolateral membrane of renal proximal tubule
by pertussis toxin (Per. Tx.). Pertussis toxin concentration was
increased from 0.01 Wg ml31 to 2.0 Wg ml31. 1038 M AG II
was added where indicated. ATPase activity was measured as
described in Section 2 (n = 4). Results are expressed as absolute
values of the enzyme activity. *Statistically signi¢cant when
compared to control (P6 0.05).
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pertussis toxin alone did not change the ATPase
activity (4.64 þ 0.73 and 5.58 þ 0.65 nmol 32Pi
mg31 min31, in the absence and in the presence of
pertussis toxin, respectively).
Fig. 9 illustrates results related to the interactions
between cholera toxin, a classical stimulatory G-pro-
tein (Gs) activator, and AG II. In the presence of
1039 M cholera toxin the Na-ATPase activity in-
creased from 6.24 þ 0.83 nmol 32Pi min31 mg31 (con-
trol) to 12.47 þ 1.07 nmol 32Pi min31 mg31. Similarly,
the simultaneous addition of 1039 M cholera toxin
and 1038 M AG II raised the Na-ATPase activity
to 11.53 þ 0.72 nmol 32Pi min31 mg31. These results
demonstrate the lack of additivity of the AG II and
cholera toxin stimulatory e¡ects. Based on these
data, it is possible to conclude that AG II activates
the Na-ATPase activity via a pertussis toxin-insen-
sitive and cholera toxin-sensitive G-protein.
3.4. Possible involvement of cAMP on the e¡ect of
AG II on the enzyme activity
It has been described that intracellular cAMP lev-
els modulate the e¡ect of AGII in proximal tubule
cells [28]. To determine the role of cAMP on the
e¡ect of AG II on the Na-ATPase activity present
in the basolateral membrane of the proximal tubule
experiments were performed in the presence of dibu-
tyryl-cAMP (d-cAMP) and protein kinase A inhibi-
tor peptide (PKAi), as shown in Fig. 10. Neither
5 WM d-cAMP nor 10 nM PKAi changed the Na-
ATPase activity either in the presence or in the ab-
sence of 1038 M AG II. These data indicate that the
e¡ect of AG II on the Na-ATPase activity is not
mediated by cAMP.
4. Discussion
In the present work, we studied the regulation of
the Na-ATPase and Na,K-ATPase activities of
the proximal tubules basolateral membrane from
pig kidney by AG II. It was observed that AG II
has a selective e¡ect on the Na-ATPase activity
but does not regulate, at least directly, the
Na,K-ATPase activity. Proverbio et al. [30] de-
scribed two forms of Na-stimulated ATPase activity
in aged microsomal fractions from guinea-pig kidney
cortex. One is the well known ouabain-sensitive
Na,K-ATPase, the other is the ouabain-insensi-
tive, Na-stimulated ATPase activity, which is sensi-
tive to ethacrynic acid and furosemide. Proverbio
and Del Castillo [31] showed, in basolateral mem-
branes from proximal tubular cells of guinea-pigs,
the presence of an ouabain-insensitive Na-stimu-
lated ATPase activity. The expression of this enzyme
was demonstrated in di¡erent cells of several species
[15,17,18]. Using the same preparation, we had pre-
viously observed that an increase in Na concentra-
tion, in the presence of 1 mM ouabain, raised the
ATPase activity inhibited by 2 mM furosemide [32].
This ATPase activity, that is 10 times lower than the
Na,K-ATPase activity, did not change with the
addition of K to a ¢nal concentration of 30 mM.
These data indicate that the basolateral membrane of
proximal tubule cells from pig kidney expresses both
Na-ATPase and Na,K-ATPase activities. Fur-
thermore, we also observed that AG II increases, in
a similar way, both the Na stimulated and the fu-
rosemide-sensitive ATPase activity, indicating that
the e¡ect of AG II is speci¢c for the ouabain-insen-
sitive Na-ATPase activity (data not shown).
It is well characterized that some of the physiolog-
ical e¡ects of the renin^angiotensin system are due,
Fig. 10. Possible involvement of cAMP in the e¡ect of AG II
on the enzyme activity. Where indicated, 5 WM dibutyryl-cAMP
(d-cAMP), 10 nM protein kinase A peptide inhibitor (PKAi)
and 1038 M AG II were added. ATPase activity was measured
as indicated in Section 2 (n = 6). 1038 M AG II was added
where indicated. Results are expressed as absolute values of the
enzyme activity. *Statistically signi¢cant when compared to
control (P6 0.05).
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in part, to the direct modulation of renal transport-
ers by AG II [1]. It has been described that low
concentrations of AG II (10312 to 10310 M) increase
sodium and water reabsorption in the proximal tu-
bules [3,33^35]. However, the mechanism involved in
this e¡ect is still unclear. Our data demonstrate that
AG II, in a concentration as low as 10310 M, in-
creases the Na-ATPase activity in both prepara-
tions by 82% (Fig. 1). Considering that AG II plays
a central role in extracellular volume regulation
through its action in sodium reabsorption, we pro-
pose that direct modulation of the Na-ATPase
might be a mechanism by which the hormone exerts
this function. This hypothesis is in agreement with
Munday and coworkers [19] who suggest that AG II
increases sodium extrusion in rat kidney cortex slices
through the activation of a ouabain-insensitive Na
pump.
The presence of AG II receptors in the cortical
nephron segments, mainly in the convoluted proxi-
mal tubules, was demonstrated in rat kidney by auto-
radiographic studies using I125-AG II [36]. In the
proximal tubule the AG II receptors are uniformly
distributed in both luminal and basolateral mem-
branes [9,37]. Burns et al. [9] showed that over 80%
of the AG II receptors found in the basolateral mem-
brane of proximal tubules from rat and rabbit kid-
neys are of the AT1 type. The stimulatory e¡ect of
AG II on the Na-ATPase activity is mediated by
receptor binding, since it was observed that saralasin
completely abolished this AG II action (Fig. 2). The
AT1 receptor has disul¢de bonds linking its four ex-
tracellular domains, making it susceptible to the re-
ducing power of thiols, such as dithiothreitol (DTT)
[8]. We suggest that AG II regulates the Na-ATPase
activity through AT1 receptors because the experi-
ments performed in the presence of DTT failed to
describe the AG II stimulatory action on the ATPase
activity (Fig. 3). The con¢rmation of the receptor
type mediating AG II function, as well as the com-
prehension of its biological actions, can only be
achieved with the use of selective non-peptide antag-
onists such as losartan and PD123319 [38]. AT1 re-
ceptors are sensitive to nano- and micromolar con-
centrations, whereas AT2 receptors are sensitive to
PD123319, but only to millimolar concentrations of
losartan [39]. As indicated in Fig. 4, the AG II stim-
ulating e¡ect on the Na-ATPase activity is abol-
ished by losartan in a nanomolar range. Besides,
PD123319 did not revert the e¡ect of AG II on the
enzyme activity (Fig. 5). These data con¢rm our hy-
pothesis that the e¡ect of AG II on the Na-ATPase
activity of the proximal tubule is mediated by AT1
subtype receptors. The involvement of AT1 receptors
on the e¡ect of AG II in di¡erent transporters of the
proximal tubule has been described in other papers
[40,41]. The increase in sodium reabsorption in prox-
imal tubule has been associated to the modulation of
three di¡erent transporters: 1) the basolateral Na/
HCO33 [42]; 2) the basolateral Na
,K-ATPase [43] ;
3) the luminal Na/H exchanger [41]. These data
indicate that AG II modulates the Na transport
in both luminal and basolateral membranes. Aperia
et al. (1994) [43] observed that AG II, in concentra-
tions as low as 10311 M, increased the Na,K-AT-
Pase activity in the presence of subsaturating concen-
trations of Na but had no e¡ect in the presence of
saturating Na concentrations. In our experiments,
we observed that AG II did not change the Na,K-
ATPase activity (Fig. 1). This apparent contradiction
could be due to the use of saturating Na concen-
trations in our experiments. The possible e¡ect of
AG II observed in this paper can not be attributed
to the modulation of the Na/H exchanger or the
Na/HCO33 transporter since: (1) The preparation
used was enriched in basolateral membrane, and
the Na/H exchanger, involved in sodium reabsorp-
tion, is located in the luminal membrane; and (2)
furosemide does not inhibit these transporters [14].
Taken together these data suggest that the e¡ect of
AG II on Na reabsorption in the proximal tubule
involves several transporters, including the ouabain-
insensitive Na-ATPase. It is plausible to postulate
that modulation of the Na,K-ATPase activity
could be correlated to the gross Na reabsorption,
while modulation of the ouabain-insensitive Na-
ATPase would represent the ¢ne adjustment of
Na reabsorption.
The AT1 receptor mediated e¡ect of AG II has
been described to be coupled to a G-protein [8,27].
In this work, we used the non-hydrolysable GTP
analogue, GTPQS, and a non-hydrolysable GDP ana-
logue, GDPLS to characterize G-protein involve-
ment. In this context, GTPQS enhanced Na-ATPase
activity in a dose-dependent manner, compatible
with AG II mechanism (Fig. 6). On the other
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hand, GDPLS reverted the AG II stimulatory action
on the enzyme activity (Fig. 7). It was recently re-
viewed by Douglas and Hopfer [28] that some of the
G-proteins can be identi¢ed due to their sensitivity to
toxins as well as by their speci¢c interactions with
e¡ectors. The members of the stimulatory G-protein
catalytic subunits (GKs) are well described as adenyl-
yl cyclase activators, and therefore enhance the
cAMP intracellular levels. In addition, they are acti-
vated by cholera toxin. On the other hand, the in-
hibitory G-protein catalytic subunits (GKi), which
promote a reduction on cAMP intracellular levels
through the inactivation of adenylyl cyclase, are in-
hibited by pertussis toxin. Our results demonstrate
that the G-protein activated by AG II, involved in
the stimulation of Na-ATPase in proximal tubules
basolateral membrane, is insensitive to pertussis tox-
in (Fig. 8). In fact, we further documented that AG
II acts through a cholera toxin sensitive G-protein,
which in turn stimulates cellular messengers that en-
hance the activity of the enzyme studied (Fig. 9).
In this paper we also investigate the possible in-
volvement of cAMP on e¡ect of AG II on the Na-
ATPase activity. It has been observed that the stim-
ulation of the Na/H exchanger present in the lu-
minal membrane of the proximal tubule cells is medi-
ated a the decrease in the cAMP intracellular level
[7]. The activation of Na-ATPase by AG II is not
mediated by a decrease in cAMP level since this ef-
fect is not reversed by pertussis toxin or by d-cAMP
(Figs. 8 and 10). On the other hand, the observation
that cholera toxin mimicked the e¡ect of AG II on
the Na-ATPase activity could suggest that the acti-
vation of the adenylyl cyclase (Fig. 9) and conse-
quent increase in cAMP level would be the signaling
pathway. This hypothesis can be ruled out since pro-
tein kinase A inhibitor peptide did not change the
e¡ect of AG II (Fig. 10). The elements involved in
cellular signaling remain to be elucidated.
The physiological role of the furosemide-sensitive
Na-ATPase is still unclear. Initially, it was pro-
posed that the Na-ATPase could be involved in
cell volume regulation [14^16]. Recently, we observed
that adenosine and bradykinin, natriuretic com-
pounds, inhibit the Na-ATPase activity but do
not change the Na,K-ATPase activity in isolated
basolateral membrane of the proximal tubule and
cortex homogenate from pig kidney [16,17]. The
data presented in this paper reveals that AG II has
also a selective e¡ect on the Na-ATPase activity.
These observations suggest that the primary active
transport target involved in the regulation of sodium
reabsorption in the proximal tubule by natriuretic
and antinatriuretic compounds is the ouabain-insen-
sitive Na-ATPase and not the ouabain-sensitive
Na,K- ATPase.
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